The use of LOX inhibitors, such as Pdcd4 and β-aminopropionitrile, decreases the invasive capacity of the breast tumor cell lines T47D and MCF7 [35] and reverses LOX-induced EMT, invasion and metastasis in cervical cancer [36]. This evidence concerns the gene LOX and breast neoplasm.